This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Galderma receives FDA approval of novel treatment option for rosacea patients
Galderma Laboratories, L.P. have announced that the US Food and Drug Administration (FDA) approved Soolantra® (ivermectin) Cream, 1% for the once-daily topical treatment of inflammatory lesions, or bumps and pimples,
